Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023
Wave Life Sciences Ltd. will host a live webcast and conference call on November 9, 2023, to review their third quarter 2023 financial results and provide business updates. Analysts can join the conference call and a recorded version will be available on the company's website.
11/03/2023 - 04:05 PM
CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, November 9, 2023, to review the company’s third quarter 2023 financial results and provide business updates.
The webcast and conference call may be accessed by visiting “Investor Events” on the investor relations section of the Wave Life Sciences website: ir.wavelifesciences.com/events-and-presentations .
Analysts planning to participate during the Q&A portion of the live call can join the conference call at the following audio conferencing link: available here . Once registered, participants will receive the dial-in information.
Following the live event, an archived version of the webcast will be available on the Wave Life Sciences website.
About Wave Life Sciences Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on X (formerly Twitter) @WaveLifeSci .
Investor Contact: Kate Rausch 617-949-4827 krausch@wavelifesci.com Media Contact: Alicia Suter 617-949-4817asuter@wavelifesci.com
When will Wave Life Sciences host the webcast and conference call?
Wave Life Sciences will host the webcast and conference call on Thursday, November 9, 2023.
What is the purpose of the webcast and conference call?
The purpose of the webcast and conference call is to review the company's third quarter 2023 financial results and provide business updates.
How can analysts participate in the Q&A portion of the live call?
Analysts can join the conference call at the provided audio conferencing link to participate in the Q&A portion.
Where can the webcast and conference call be accessed?
The webcast and conference call can be accessed by visiting the 'Investor Events' section on the Wave Life Sciences website.
Will a recorded version of the webcast be available?
Yes, an archived version of the webcast will be available on the Wave Life Sciences website after the live event.
Wave Life Sciences Ltd.
NASDAQ:WVE
WVE Rankings
#1217 Ranked by Stock Gains
WVE Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
Singapore
City
7 Straits View
About WVE
wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.